
    
      The primary objective is to assess the use of the thoracic bifurcation and the visceral
      manifold stent graft system to repair thoracoabdominal aortic aneurysms in patients with
      appropriate anatomy. The primary intent of the study is to assess safety (i.e. freedom from
      major adverse events (MAE) at 30 days) and preliminary effectiveness (i.e., treatment success
      and technical success) of the device (i.e., the proportion of treatment group subjects that
      achieve and maintain treatment success at one year). Additionally, the study will assess
      technical success and treatment success at each follow-up interval.
    
  